Keywords
Last Name
Institution

NIKOLAOS GEORGI FRANGOGIANNIS

TitleAdjunct Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6565 Fannin - MS BCM 620
Fondren-Brown Romm F624
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chen B, Frangogiannis NG. Macrophages in the Remodeling Failing Heart. Circ Res. 2016 Sep 16; 119(7):776-8. PMID: 27635078.
      View in: PubMed
    2. Frunza O, Russo I, Shinde AV, Su Y, Frangogiannis NG. Authors' Reply. Am J Pathol. 2016 Aug; 186(8):2234-5. PMID: 27461365; PMCID: PMC4973651 [Available on 08/01/17].
    3. Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 2016 Jun 24; 119(1):91-112. PMID: 27340270; PMCID: PMC4922528 [Available on 06/24/17].
    4. Frunza O, Russo I, Saxena A, Shinde AV, Humeres C, Hanif W, Rai V, Su Y, Frangogiannis NG. Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis. Am J Pathol. 2016 May; 186(5):1114-27. PMID: 26948424; PMCID: PMC4861760 [Available on 05/01/17].
    5. Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2016 Jan; 90:84-93. PMID: 26705059.
      View in: PubMed
    6. Saxena A, Shinde AV, Haque Z, Wu YJ, Chen W, Su Y, Frangogiannis NG. The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction. J Mol Cell Cardiol. 2015 Dec; 89(Pt B):223-31. PMID: 26542797.
      View in: PubMed
    7. Frangogiannis NG. Pathophysiology of Myocardial Infarction. Compr Physiol. 2015 Oct; 5(4):1841-75. PMID: 26426469.
      View in: PubMed
    8. Frangogiannis NG. Emerging roles for macrophages in cardiac injury: cytoprotection, repair, and regeneration. J Clin Invest. 2015 Aug 3; 125(8):2927-30. PMID: 26214519.
      View in: PubMed
    9. Saxena A, Russo I, Frangogiannis NG. Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges. Transl Res. 2016 Jan; 167(1):152-66. PMID: 26241027.
      View in: PubMed
    10. Shinde AV, Frangogiannis NG. Mediators secreted by myeloid cells may protect and repair the infarcted myocardium. Circ Res. 2015 Jun 19; 117(1):10-2. PMID: 26089362.
      View in: PubMed
    11. Frangogiannis NG. The reparative function of cardiomyocytes in the infarcted myocardium. Cell Metab. 2015 Jun 2; 21(6):797-8. PMID: 26039445.
      View in: PubMed
    12. Biernacka A, Cavalera M, Wang J, Russo I, Shinde A, Kong P, Gonzalez-Quesada C, Rai V, Dobaczewski M, Lee DW, Wang XF, Frangogiannis NG. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice. Circ Heart Fail. 2015 Jul; 8(4):788-98. PMID: 25985794.
      View in: PubMed
    13. Frangogiannis NG. Inflammation in cardiac injury, repair and regeneration. Curr Opin Cardiol. 2015 May; 30(3):240-5. PMID: 25807226; PMCID: PMC4401066.
    14. Frangogiannis NG. Targeting the transforming growth factor (TGF)-? cascade in the remodeling heart: benefits and perils. J Mol Cell Cardiol. 2014 Nov; 76:169-71. PMID: 25218305; PMCID: PMC4408532.
    15. Saxena A, Dobaczewski M, Rai V, Haque Z, Chen W, Li N, Frangogiannis NG. Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am J Physiol Heart Circ Physiol. 2014 Oct 15; 307(8):H1233-42. PMID: 25128167; PMCID: PMC4200341.
    16. Saxena A, Bujak M, Frunza O, Dobaczewski M, Gonzalez-Quesada C, Lu B, Gerard C, Frangogiannis NG. CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans. Cardiovasc Res. 2014 Jul 15; 103(2):217-27. PMID: 24891401; PMCID: PMC4148609.
    17. Cavalera M, Wang J, Frangogiannis NG. Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl Res. 2014 Oct; 164(4):323-35. PMID: 24880146; PMCID: PMC4180761.
    18. Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014 May; 11(5):255-65. PMID: 24663091; PMCID: PMC4407144.
    19. Frangogiannis NG. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol. 2014 Mar; 63(3):185-95. PMID: 24072174; PMCID: PMC3949163.
    20. Rienks M, Papageorgiou AP, Frangogiannis NG, Heymans S. Myocardial extracellular matrix: an ever-changing and diverse entity. Circ Res. 2014 Feb 28; 114(5):872-88. PMID: 24577967.
      View in: PubMed
    21. Frangogiannis NG. Contribution of extramedullary organs in myocardial inflammation and remodeling: does the spleen cause cardiac melancholy? Circ Res. 2014 Jan 17; 114(2):230-2. PMID: 24436423; PMCID: PMC4040257.
    22. Cavalera M, Frangogiannis NG. Targeting the chemokines in cardiac repair. Curr Pharm Des. 2014; 20(12):1971-9. PMID: 23844733; PMCID: PMC4408530.
    23. Shinde AV, Frangogiannis NG. Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol. 2014 May; 70:74-82. PMID: 24321195; PMCID: PMC3995820.
    24. Frangogiannis NG. MicroRNAs and endothelial function: many challenges and early hopes for clinical applications. J Am Coll Cardiol. 2014 Apr 29; 63(16):1695-6. PMID: 24291271.
      View in: PubMed
    25. Kong P, Cavalera M, Frangogiannis NG. The role of thrombospondin (TSP)-1 in obesity and diabetes. Adipocyte. 2014 Jan 1; 3(1):81-4. PMID: 24575376; PMCID: PMC3917940.
    26. Gonzalez-Quesada C, Cavalera M, Biernacka A, Kong P, Lee DW, Saxena A, Frunza O, Dobaczewski M, Shinde A, Frangogiannis NG. Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Circ Res. 2013 Dec 6; 113(12):1331-44. PMID: 24081879; PMCID: PMC4408537.
    27. Saxena A, Chen W, Su Y, Rai V, Uche OU, Li N, Frangogiannis NG. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J Immunol. 2013 Nov 1; 191(9):4838-48. PMID: 24078695; PMCID: PMC3822582.
    28. Kong P, Christia P, Saxena A, Su Y, Frangogiannis NG. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am J Physiol Heart Circ Physiol. 2013 Nov 1; 305(9):H1363-72. PMID: 23997102; PMCID: PMC3840245.
    29. Christia P, Frangogiannis NG. Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest. 2013 Sep; 43(9):986-95. PMID: 23772948; PMCID: PMC3745791.
    30. Kong P, Gonzalez-Quesada C, Li N, Cavalera M, Lee DW, Frangogiannis NG. Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation. Am J Physiol Endocrinol Metab. 2013 Aug 1; 305(3):E439-50. PMID: 23757408; PMCID: PMC3742854.
    31. Christia P, Bujak M, Gonzalez-Quesada C, Chen W, Dobaczewski M, Reddy A, Frangogiannis NG. Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction. J Histochem Cytochem. 2013 Aug; 61(8):555-70. PMID: 23714783; PMCID: PMC3724390.
    32. Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014 Feb; 71(4):549-74. PMID: 23649149; PMCID: PMC3769482.
    33. Chen W, Saxena A, Li N, Sun J, Gupta A, Lee DW, Tian Q, Dobaczewski M, Frangogiannis NG. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler Thromb Vasc Biol. 2012 Nov; 32(11):2598-608. PMID: 22995519; PMCID: PMC3510666.
    34. Chen W, Frangogiannis NG. Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta. 2013 Apr; 1833(4):945-53. PMID: 22982064; PMCID: PMC3541439.
    35. Dobaczewski M, de Haan JJ, Frangogiannis NG. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res. 2012 Dec; 5(6):837-47. PMID: 22956156; PMCID: PMC3535072.
    36. Frangogiannis NG. Monomeric C-reactive protein and inflammatory injury in myocardial infarction. Cardiovasc Res. 2012 Oct 1; 96(1):4-6. PMID: 22871589; PMCID: PMC3444236.
    37. Frangogiannis NG. Matricellular proteins in cardiac adaptation and disease. Physiol Rev. 2012 Apr; 92(2):635-88. PMID: 22535894; PMCID: PMC4411042.
    38. Frangogiannis NG. Biomarkers: hopes and challenges in the path from discovery to clinical practice. Transl Res. 2012 Apr; 159(4):197-204. PMID: 22424424; PMCID: PMC4402218.
    39. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012 Jan 6; 110(1):159-73. PMID: 22223212; PMCID: PMC3690135.
    40. Frangogiannis NG. The stromal cell-derived factor-1/CXCR4 axis in cardiac injury and repair. J Am Coll Cardiol. 2011 Nov 29; 58(23):2424-6. PMID: 22115650.
      View in: PubMed
    41. Xia Y, Dobaczewski M, Gonzalez-Quesada C, Chen W, Biernacka A, Li N, Lee DW, Frangogiannis NG. Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension. 2011 Nov; 58(5):902-11. PMID: 21947471; PMCID: PMC3199343.
    42. Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-? signaling in fibrosis. Growth Factors. 2011 Oct; 29(5):196-202. PMID: 21740331; PMCID: PMC4408550.
    43. Frangogiannis NG. Stromal cell-derived factor-1-mediated angiogenesis for peripheral arterial disease: ready for prime time? Circulation. 2011 Mar 29; 123(12):1267-9. PMID: 21403099.
      View in: PubMed
    44. Dobaczewski M, Frangogiannis NG. The cellular specificity of leptin-mediated actions in the infarcted heart. Cardiovasc Res. 2011 Jan 1; 89(1):9-11. PMID: 21062917; PMCID: PMC3002876.
    45. Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-? signaling in cardiac remodeling. J Mol Cell Cardiol. 2011 Oct; 51(4):600-6. PMID: 21059352; PMCID: PMC3072437.
    46. Chen W, Frangogiannis NG. The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev. 2010 Sep; 15(5):415-22. PMID: 20213186; PMCID: PMC2920375.
    47. Dobaczewski M, Bujak M, Li N, Gonzalez-Quesada C, Mendoza LH, Wang XF, Frangogiannis NG. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res. 2010 Aug 6; 107(3):418-28. PMID: 20522804; PMCID: PMC2917472.
    48. Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol. 2010 May; 176(5):2177-87. PMID: 20382703; PMCID: PMC2861083.
    49. Frangogiannis NG. Syndecan-1: a critical mediator in cardiac fibrosis. Hypertension. 2010 Feb; 55(2):233-5. PMID: 20048190; PMCID: PMC2819313.
    50. Durgan DJ, Pulinilkunnil T, Villegas-Montoya C, Garvey ME, Frangogiannis NG, Michael LH, Chow CW, Dyck JR, Young ME. Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ Res. 2010 Feb 19; 106(3):546-50. PMID: 20007913; PMCID: PMC3021132.
    51. Bujak M, Dobaczewski M, Gonzalez-Quesada C, Xia Y, Leucker T, Zymek P, Veeranna V, Tager AM, Luster AD, Frangogiannis NG. Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res. 2009 Nov 6; 105(10):973-83. PMID: 19797174; PMCID: PMC2783369.
    52. Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol. 2010 Mar; 48(3):504-11. PMID: 19631653; PMCID: PMC2824059.
    53. Dobaczewski M, Frangogiannis NG. Chemokines and cardiac fibrosis. Front Biosci (Schol Ed). 2009; 1:391-405. PMID: 19482709; PMCID: PMC2798729.
    54. Bujak M, Frangogiannis NG. The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp (Warsz). 2009 May-Jun; 57(3):165-76. PMID: 19479203; PMCID: PMC2788964.
    55. Gonzalez-Quesada C, Frangogiannis NG. Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes. Curr Atheroscler Rep. 2009 Mar; 11(2):131-8. PMID: 19228487; PMCID: PMC2787514.
    56. Xia Y, Lee K, Li N, Corbett D, Mendoza L, Frangogiannis NG. Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol. 2009 Apr; 131(4):471-81. PMID: 19030868; PMCID: PMC2782393.
    57. Thakker GD, Frangogiannis NG, Zymek PT, Sharma S, Raya JL, Barger PM, Taegtmeyer H, Entman ML, Ballantyne CM. Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity. Obesity (Silver Spring). 2008 Dec; 16(12):2593-600. PMID: 18833212; PMCID: PMC3049112.
    58. Dobaczewski M, Frangogiannis NG. Chemokines in myocardial infarction: translating basic research into clinical medicine. Future Cardiol. 2008 Jul; 4(4):347-51. PMID: 19804314.
      View in: PubMed
    59. Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res. 2008 Aug; 58(2):88-111. PMID: 18620057; PMCID: PMC2642482.
    60. Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, Frangogiannis NG. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol. 2008 Jul; 173(1):57-67. PMID: 18535174; PMCID: PMC2438285.
    61. Bujak M, Kweon HJ, Chatila K, Li N, Taffet G, Frangogiannis NG. Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol. 2008 Apr 8; 51(14):1384-92. PMID: 18387441; PMCID: PMC3348616.
    62. Huebener P, Abou-Khamis T, Zymek P, Bujak M, Ying X, Chatila K, Haudek S, Thakker G, Frangogiannis NG. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol. 2008 Feb 15; 180(4):2625-33. PMID: 18250474.
      View in: PubMed
    63. Rao L, Ling Y, He R, Gilbert AL, Frangogiannis NG, Wang J, Nagueh SF, Khoury DS. Integrated multimodal-catheter imaging unveils principal relationships among ventricular electrical activity, anatomy, and function. Am J Physiol Heart Circ Physiol. 2008 Feb; 294(2):H1002-9. PMID: 18083892.
      View in: PubMed
    64. Frangogiannis NG. The prognostic value of monocyte chemoattractant protein-1/CCL2 in acute coronary syndromes. J Am Coll Cardiol. 2007 Nov 27; 50(22):2125-7. PMID: 18036448.
      View in: PubMed
    65. Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation. 2007 Nov 6; 116(19):2127-38. PMID: 17967775.
      View in: PubMed
    66. Xia Y, Frangogiannis NG. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm Allergy Drug Targets. 2007 Jun; 6(2):101-7. PMID: 17692033.
      View in: PubMed
    67. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost. 2007 May; 97(5):738-47. PMID: 17479184.
      View in: PubMed
    68. Frangogiannis NG, Dewald O, Xia Y, Ren G, Haudek S, Leucker T, Kraemer D, Taffet G, Rollins BJ, Entman ML. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation. 2007 Feb 6; 115(5):584-92. PMID: 17283277.
      View in: PubMed
    69. Chatila K, Ren G, Xia Y, Huebener P, Bujak M, Frangogiannis NG. The role of the thrombospondins in healing myocardial infarcts. Cardiovasc Hematol Agents Med Chem. 2007 Jan; 5(1):21-7. PMID: 17266545.
      View in: PubMed
    70. Zymek P, Nah DY, Bujak M, Ren G, Koerting A, Leucker T, Huebener P, Taffet G, Entman M, Frangogiannis NG. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Cardiovasc Res. 2007 May 1; 74(2):313-22. PMID: 17188669; PMCID: PMC1924681.
    71. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, Pilling D, Gomer RH, Trial J, Frangogiannis NG, Entman ML. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A. 2006 Nov 28; 103(48):18284-9. PMID: 17114286; PMCID: PMC1643845.
    72. Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, Frangogiannis NG. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol. 2006 Dec 5; 48(11):2315-23. PMID: 17161265.
      View in: PubMed
    73. Frangogiannis NG. The mechanistic basis of infarct healing. Antioxid Redox Signal. 2006 Nov-Dec; 8(11-12):1907-39. PMID: 17034340.
      View in: PubMed
    74. Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007 May 1; 74(2):184-95. PMID: 17109837; PMCID: PMC1924687.
    75. Thakker GD, Frangogiannis NG, Bujak M, Zymek P, Gaubatz JW, Reddy AK, Taffet G, Michael LH, Entman ML, Ballantyne CM. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006 Nov; 291(5):H2504-14. PMID: 16731644.
      View in: PubMed
    76. Dobaczewski M, Bujak M, Zymek P, Ren G, Entman ML, Frangogiannis NG. Extracellular matrix remodeling in canine and mouse myocardial infarcts. Cell Tissue Res. 2006 Jun; 324(3):475-88. PMID: 16496177.
      View in: PubMed
    77. Frangogiannis NG, Entman ML. Identification of mast cells in the cellular response to myocardial infarction. Methods Mol Biol. 2006; 315:91-101. PMID: 16110151.
      View in: PubMed
    78. Frangogiannis NG. Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem. 2006; 13(16):1877-93. PMID: 16842199.
      View in: PubMed
    79. Park TH, Nagueh SF, Khoury DS, Kopelen HA, Akrivakis S, Nasser K, Ren G, Frangogiannis NG. Impact of myocardial structure and function postinfarction on diastolic strain measurements: implications for assessment of myocardial viability. Am J Physiol Heart Circ Physiol. 2006 Feb; 290(2):H724-31. PMID: 16183729.
      View in: PubMed
    80. Frangogiannis NG, Entman ML. Chemokines in myocardial ischemia. Trends Cardiovasc Med. 2005 Jul; 15(5):163-9. PMID: 16165012.
      View in: PubMed
    81. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation. 2005 Jun 7; 111(22):2935-42. PMID: 15927970.
      View in: PubMed
    82. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005 Apr 29; 96(8):881-9. PMID: 15774854.
      View in: PubMed
    83. Somasundaram P, Ren G, Nagar H, Kraemer D, Mendoza L, Michael LH, Caughey GH, Entman ML, Frangogiannis NG. Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol. 2005 Jan; 205(1):102-11. PMID: 15586361; PMCID: PMC2275298.
    84. Frangogiannis NG. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res. 2004 Nov; 53(11):585-95. PMID: 15693606.
      View in: PubMed
    85. Dewald O, Frangogiannis NG, Zoerlein MP, Duerr GD, Taffet G, Michael LH, Welz A, Entman ML. A murine model of ischemic cardiomyopathy induced by repetitive ischemia and reperfusion. Thorac Cardiovasc Surg. 2004 Oct; 52(5):305-11. PMID: 15470614.
      View in: PubMed
    86. Frangogiannis NG, Entman ML. Targeting the chemokines in myocardial inflammation. Circulation. 2004 Sep 14; 110(11):1341-2. PMID: 15364818.
      View in: PubMed
    87. Dobaczewski M, Akrivakis S, Nasser K, Michael LH, Entman ML, Frangogiannis NG. Vascular mural cells in healing canine myocardial infarcts. J Histochem Cytochem. 2004 Aug; 52(8):1019-29. PMID: 15258177.
      View in: PubMed
    88. Frangogiannis NG. The role of the chemokines in myocardial ischemia and reperfusion. Curr Vasc Pharmacol. 2004 Apr; 2(2):163-74. PMID: 15320517.
      View in: PubMed
    89. Dewald O, Ren G, Duerr GD, Zoerlein M, Klemm C, Gersch C, Tincey S, Michael LH, Entman ML, Frangogiannis NG. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol. 2004 Feb; 164(2):665-77. PMID: 14742270; PMCID: PMC1602262.
    90. Ren G, Dewald O, Frangogiannis NG. Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy. 2003 Sep; 2(3):242-56. PMID: 14561159.
      View in: PubMed
    91. Frangogiannis NG. Myocardial hibernation. Clinical and pathological perspectives. Minerva Cardioangiol. 2003 Jun; 51(3):261-74. PMID: 12867878.
      View in: PubMed
    92. Frangogiannis NG, Mendoza LH, Ren G, Akrivakis S, Jackson PL, Michael LH, Smith CW, Entman ML. MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am J Physiol Heart Circ Physiol. 2003 Aug; 285(2):H483-92. PMID: 12689859.
      View in: PubMed
    93. Frangogiannis NG. The pathological basis of myocardial hibernation. Histol Histopathol. 2003 Apr; 18(2):647-55. PMID: 12647814.
      View in: PubMed
    94. Dewald O, Frangogiannis NG, Zoerlein M, Duerr GD, Klemm C, Knuefermann P, Taffet G, Michael LH, Crapo JD, Welz A, Entman ML. Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species. Proc Natl Acad Sci U S A. 2003 Mar 4; 100(5):2700-5. PMID: 12586861; PMCID: PMC151404.
    95. Shimoni S, Frangogiannis NG, Aggeli CJ, Shan K, Verani MS, Quinones MA, Espada R, Letsou GV, Lawrie GM, Winters WL, Reardon MJ, Zoghbi WA. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation. 2003 Feb 4; 107(4):538-44. PMID: 12566363.
      View in: PubMed
    96. Fernandes LS, Conde ID, Wayne Smith C, Kansas GS, Snapp KR, Bennet N, Ballantyne C, McIntire LV, O'Brian Smith E, Klem JA, Mathew S, Frangogiannis N, Turner NA, Maresh KJ, Kleiman NS. Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting. Thromb Res. 2003; 111(3):171-7. PMID: 14678816.
      View in: PubMed
    97. Shimoni S, Frangogiannis NG, Aggeli CJ, Shan K, Quinones MA, Espada R, Letsou GV, Lawrie GM, Winters WL, Reardon MJ, Zoghbi WA. Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernation. Circulation. 2002 Aug 20; 106(8):950-6. PMID: 12186799.
      View in: PubMed
    98. Gersch C, Dewald O, Zoerlein M, Michael LH, Entman ML, Frangogiannis NG. Mast cells and macrophages in normal C57/BL/6 mice. Histochem Cell Biol. 2002 Jul; 118(1):41-9. PMID: 12122446.
      View in: PubMed
    99. Frangogiannis NG, Shimoni S, Chang SM, Ren G, Dewald O, Gersch C, Shan K, Aggeli C, Reardon M, Letsou GV, Espada R, Ramchandani M, Entman ML, Zoghbi WA. Active interstitial remodeling: an important process in the hibernating human myocardium. J Am Coll Cardiol. 2002 May 1; 39(9):1468-74. PMID: 11985909.
      View in: PubMed
    100. Frangogiannis NG, Shimoni S, Chang SM, Ren G, Shan K, Aggeli C, Reardon MJ, Letsou GV, Espada R, Ramchandani M, Entman ML, Zoghbi WA. Evidence for an active inflammatory process in the hibernating human myocardium. Am J Pathol. 2002 Apr; 160(4):1425-33. PMID: 11943726; PMCID: PMC1867231.
    101. Ren G, Michael LH, Entman ML, Frangogiannis NG. Morphological characteristics of the microvasculature in healing myocardial infarcts. J Histochem Cytochem. 2002 Jan; 50(1):71-9. PMID: 11748296.
      View in: PubMed
    102. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002 Jan; 53(1):31-47. PMID: 11744011.
      View in: PubMed
    103. Nossuli TO, Frangogiannis NG, Knuefermann P, Lakshminarayanan V, Dewald O, Evans AJ, Peschon J, Mann DL, Michael LH, Entman ML. Brief murine myocardial I/R induces chemokines in a TNF-alpha-independent manner: role of oxygen radicals. Am J Physiol Heart Circ Physiol. 2001 Dec; 281(6):H2549-58. PMID: 11709422.
      View in: PubMed
    104. Lakshminarayanan V, Lewallen M, Frangogiannis NG, Evans AJ, Wedin KE, Michael LH, Entman ML. Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia. Am J Pathol. 2001 Oct; 159(4):1301-11. PMID: 11583958; PMCID: PMC1850518.
    105. Frangogiannis NG, Mendoza LH, Lewallen M, Michael LH, Smith CW, Entman ML. Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis. FASEB J. 2001 Jun; 15(8):1428-30. PMID: 11387246.
      View in: PubMed
    106. Frangogiannis NG, Mendoza LH, Smith CW, Michael LH, Entman ML. Induction of the synthesis of the C-X-C chemokine interferon-gamma-inducible protein-10 in experimental canine endotoxemia. Cell Tissue Res. 2000 Dec; 302(3):365-76. PMID: 11151448.
      View in: PubMed
    107. Frangogiannis NG, Michael LH, Entman ML. Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res. 2000 Oct; 48(1):89-100. PMID: 11033111.
      View in: PubMed
    108. Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol. 2000 Sep 1; 165(5):2798-808. PMID: 10946312.
      View in: PubMed
    109. Entman ML, Youker KA, Frangogiannis N, Lakshminarayanan V, Nossuli T, Evans A, Kurrelmeyer K, Mann DL, Smith CW. Is inflammation good for the ischemic heart--perspectives beyond the ordinary. Z Kardiol. 2000; 89 Suppl 9:IX/82-7. PMID: 11151802.
      View in: PubMed
    110. Frangogiannis NG, Farmer JA, Lakkis NM. Tirofiban for cocaine-induced coronary artery thrombosis: a novel therapeutic approach. Circulation. 1999 Nov 2; 100(18):1939. PMID: 10545440.
      View in: PubMed
    111. Frangogiannis NG, Burns AR, Michael LH, Entman ML. Histochemical and morphological characteristics of canine cardiac mast cells. Histochem J. 1999 Apr; 31(4):221-9. PMID: 10447063.
      View in: PubMed
    112. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, Entman ML. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation. 1999 Feb 2; 99(4):546-51. PMID: 9927402.
      View in: PubMed
    113. Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballantyne CM, Smith CW, Entman ML. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol. 1998 Dec; 30(12):2567-76. PMID: 9990529.
      View in: PubMed
    114. Frangogiannis NG, Cate TR. Endocarditis and Ureaplasma urealyticum osteomyelitis in a hypogammaglobulinemic patient. A case report and review of the literature. J Infect. 1998 Sep; 37(2):181-4. PMID: 9821094.
      View in: PubMed
    115. Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH, Spengler RN, Smith CW, Entman ML. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation. 1998 Aug 18; 98(7):699-710. PMID: 9715863.
      View in: PubMed
    116. Frangogiannis NG, Perrard JL, Mendoza LH, Burns AR, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation. 1998 Aug 18; 98(7):687-98. PMID: 9715862.
      View in: PubMed
    117. Youker KA, Birdsall HH, Frangogiannis NG, Kumar AG, Lindsey ML, Ballantyne CM, Smith CW, Rossen RD, Entman ML. Phagocytes in ischemia injury. Ann N Y Acad Sci. 1997 Dec 15; 832:243-65. PMID: 9704052.
      View in: PubMed
    118. Frangogiannis NG, Boridy I, Mazhar M, Mathews R, Gangopadhyay S, Cate T. Cyclophosphamide in the treatment of toxic epidermal necrolysis. South Med J. 1996 Oct; 89(10):1001-3. PMID: 8865797.
      View in: PubMed
    119. Frangogiannis NG, Youker KA, Entman ML. The role of the neutrophil in myocardial ischemia and reperfusion. EXS. 1996; 76:263-84. PMID: 8805800.
      View in: PubMed
    120. Frangogiannis NG, Gangopadhyay S, Cate T. Pemphigus of the larynx and esophagus. Ann Intern Med. 1995 May 15; 122(10):803-4. PMID: 7717612.
      View in: PubMed
    FRANGOGIANNIS's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _